Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 99 contracts
Sources: Atm Sales Agreement (Venu Holding Corp), Sales Agreement (Odysight.ai Inc.), Atm Sales Agreement (Sidus Space Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, for or purchase the Common Stock in violation of Regulation MStock, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentCommon Stock.
Appears in 81 contracts
Sources: Drawdown Equity Financing Agreement, Drawdown Equity Financing Agreement, Securities Purchase Agreement (Stragenics, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation MStock, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 75 contracts
Sources: Sales Agreement (Z Squared Inc.), Sales Agreement (Empire Petroleum Corp), Sales Agreement (Barnwell Industries Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 71 contracts
Sources: Atm Sales Agreement (Volato Group, Inc.), Atm Sales Agreement (NovaBay Pharmaceuticals, Inc.), Sales Agreement (Greenlane Holdings, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, or purchase shares of Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales Agent.
Appears in 66 contracts
Sources: Sales Agreement (LQR House Inc.), Sales Agreement (Upexi, Inc.), Sales Agreement (Inmune Bio, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 55 contracts
Sources: Sales Agreement (Filana Therapeutics, Inc.), Sales Agreement (Cassava Sciences Inc), Atm Sales Agreement (HeartBeam, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 42 contracts
Sources: At Market Issuance Sales Agreement (MultiSensor AI Holdings, Inc.), Atm Sales Agreement (Nextnrg, Inc.), Sales Agreement (Crinetics Pharmaceuticals, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentMLV.
Appears in 30 contracts
Sources: At the Market Issuance Sales Agreement, At Market Issuance Sales Agreement (NephroGenex, Inc.), At Market Issuance Sales Agreement (NephroGenex, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 22 contracts
Sources: Sales Agreement (Agriforce Growing Systems Ltd.), At Market Issuance Sales Agreement (iBio, Inc.), At Market Issuance Sales Agreement (Gryphon Digital Mining, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Ordinary Shares or (ii) sell, bid for, or purchase Common Stock Ordinary Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales Agent.
Appears in 21 contracts
Sources: Sales Agreement (IceCure Medical Ltd.), Sales Agreement (Maris Tech Ltd.), Sales Agreement (Regencell Bioscience Holdings LTD)
Market Activities. The Company will not, directly or indirectly, : (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Stock; or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 20 contracts
Sources: At the Market Issuance Sales Agreement (Alzamend Neuro, Inc.), At the Market Issuance Sales Agreement (ENDRA Life Sciences Inc.), At the Market Issuance Sales Agreement (Auddia Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentMLV.
Appears in 19 contracts
Sources: At Market Issuance Sales Agreement (GreenHunter Resources, Inc.), At Market Issuance Sales Agreement (GreenHunter Resources, Inc.), At the Market Issuance Sales Agreement (Mannkind Corp)
Market Activities. The Company will not, directly or indirectly, (i) indirectly take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentShares.
Appears in 18 contracts
Sources: At Market Issuance Sales Agreement (Agenus Inc), At Market Issuance Sales Agreement (Agenus Inc), At Market Issuance Sales Agreement (Agenus Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentCanaccord.
Appears in 17 contracts
Sources: Equity Distribution Agreement (Oncolytics Biotech Inc), Equity Distribution Agreement (Oncolytics Biotech Inc), Equity Distribution Agreement (Mohawk Group Holdings, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Placement Shares to be issued and sold pursuant to this Agreement, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales Agent.
Appears in 17 contracts
Sources: Equity Distribution Agreement (Annovis Bio, Inc.), Common Stock Sales Agreement (Akerna Corp.), Equity Distribution Agreement (Icosavax, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would could reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company Common Stock to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentShares.
Appears in 15 contracts
Sources: Sales Agency Financing Agreement (Southern Co), Sales Agency Financing Agreement (Southern Co), Sales Agency Financing Agreement (Southern Co)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 13 contracts
Sources: Sales Agreement (Riot Platforms, Inc.), Sales Agreement (Riot Platforms, Inc.), Sales Agreement (Soundhound Ai, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentMLV.
Appears in 13 contracts
Sources: Sales Agreement (Magnum Hunter Resources Corp), At Market Issuance Sales Agreement (Peregrine Pharmaceuticals Inc), Atm Sales Agreement (Magnum Hunter Resources Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Placement Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentMLV.
Appears in 12 contracts
Sources: At Market Issuance Sales Agreement (Transwitch Corp /De), At Market Issuance Sales Agreement (Wave Systems Corp), At Market Issuance Sales Agreement (Beacon Power Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.▇▇▇▇▇-▇▇▇▇▇▇, or (iii) take any action which would directly or indirectly violate Regulation M.
Appears in 11 contracts
Sources: At the Market Issuance Sales Agreement (Airgain Inc), At the Market Issuance Sales Agreement (Airgain Inc), At the Market Issuance Sales Agreement (Microvision, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Placement Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 11 contracts
Sources: Sales Agreement (Progenics Pharmaceuticals Inc), Sales Agreement (Aerie Pharmaceuticals Inc), Sales Agreement (Aerie Pharmaceuticals Inc)
Market Activities. The Company will not, directly or indirectly, (i) indirectly take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, for or purchase the Common Stock in violation of Regulation MStock, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentCommon Stock.
Appears in 11 contracts
Sources: Reserve Equity Financing Agreement (Strategic Mining Corp), Reserve Equity Financing Agreement (Smart Kids Group Inc.), Reserve Equity Financing Agreement (USA Synthetic Fuel Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent▇▇ ▇▇▇▇▇.
Appears in 10 contracts
Sources: At Market Issuance Sales Agreement (Magnum Hunter Resources Corp), At Market Issuance Sales Agreement (Generex Biotechnology Corp), At Market Issuance Sales Agreement (Peregrine Pharmaceuticals Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 10 contracts
Sources: Sales Agreement (SITIME Corp), Sales Agreement (Momentus Inc.), Sales Agreement (SITIME Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, or purchase shares of Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentSales Agents.
Appears in 10 contracts
Sources: Sales Agreement (CleanCore Solutions, Inc.), Sales Agreement (Incannex Healthcare Inc.), Sales Agreement (United States Antimony Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Shares or (ii) sell, bid for, or purchase Common Stock Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 9 contracts
Sources: At Market Issuance Sales Agreement (NORDIC AMERICAN TANKERS LTD), Atm Sales Agreement (NLS Pharmaceutics Ltd.), At Market Issuance Sales Agreement (NORDIC AMERICAN TANKERS LTD)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation MStock, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 9 contracts
Sources: Sales Agreement (HighPeak Energy, Inc.), Sales Agreement (Evolution Petroleum Corp), Sales Agreement (Synergy CHC Corp.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales Agent.
Appears in 9 contracts
Sources: Atm Sales Agreement (Flexible Solutions International Inc), Sales Agreement (FiEE, Inc.), Sales Agreement (Cheetah Net Supply Chain Service Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Shares or (ii) sell, bid for, or purchase Common Stock Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 9 contracts
Sources: Atm Sales Agreement (Vision Marine Technologies Inc.), Atm Sales Agreement (Snow Lake Resources Ltd.), Atm Sales Agreement (Vision Marine Technologies Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Shares or (ii) sell, bid for, or purchase Common Stock Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 9 contracts
Sources: At Market Issuance Sales Agreement (Tiziana Life Sciences LTD), Sales Agreement (AgeX Therapeutics, Inc.), Sales Agreement (Lineage Cell Therapeutics, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent or an Alternative Agent.
Appears in 8 contracts
Sources: At the Market Issuance Sales Agreement (Great Ajax Corp.), At the Market Issuance Sales Agreement (Great Ajax Corp.), At the Market Issuance Sales Agreement (Great Ajax Corp.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Ordinary Shares or (ii) sell, bid for, or purchase Common Stock Ordinary Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 8 contracts
Sources: Sales Agreement (ProQR Therapeutics N.V.), Sales Agreement (Gorilla Technology Group Inc.), Sales Agreement (Gorilla Technology Group Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Placement Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 8 contracts
Sources: At Market Issuance Sales Agreement (Stellus Capital Investment Corp), At Market Issuance Sales Agreement (Stellus Capital Investment Corp), At Market Issuance Sales Agreement (MONROE CAPITAL Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company or the Operating Partnership to facilitate the sale or resale of the Common Stock Shares or (ii) during any Stand Off Period sell, bid for, for or purchase the Common Stock in violation of Regulation MShares, or pay anyone any person any compensation for soliciting purchases of the Placement Common Shares other than the Agent or an Alternative Sales Agent.;
Appears in 8 contracts
Sources: Sales Agency Financing Agreement (Brandywine Operating Partnership, L.P.), Sales Agency Financing Agreement (Brandywine Operating Partnership, L.P.), Sales Agency Financing Agreement (Brandywine Operating Partnership, L.P.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization stabilization, maintenance or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Shares or (ii) sell, bid for, or purchase Common Stock Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 8 contracts
Sources: Sales Agreement (Seabridge Gold Inc), Sales Agreement (Energy Fuels Inc), Sales Agreement (Seabridge Gold Inc)
Market Activities. The Company will notnot take, directly or indirectly, (i) take any action designed to or that might be reasonably expected to cause or result in, or that constitutes or would reasonably be expected to constitute, the in stabilization or manipulation of the price of the Shares or any security of the Company other reference security, whether to facilitate the sale or resale of Common Stock the Shares or (ii) sellotherwise, bid forand the Company will, or purchase Common Stock in violation and shall cause each of its affiliates to, comply with all applicable provisions of Regulation M; provided, or pay anyone any compensation however, that the Company may bid for soliciting purchases of and purchase Common Shares in accordance with Rule 10b-18 under the Placement Shares other than Exchange Act, to the Agentextent available.
Appears in 8 contracts
Sources: Open Market Sale Agreement (Ardmore Shipping Corp), Open Market Sale Agreement (Ardmore Shipping Corp), Open Market Sale Agreement (Ardmore Shipping Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation MStock, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 8 contracts
Sources: Sales Agreement (Broadwind, Inc.), Sales Agreement (Zogenix, Inc.), Sales Agreement (Heat Biologics, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentDistribution Agents.
Appears in 7 contracts
Sources: At Market Issuance Sales Agreement (Aemetis, Inc), At Market Issuance Sales Agreement (Spectrum Pharmaceuticals Inc), At Market Issuance Sales Agreement (Aemetis, Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentMLV.
Appears in 7 contracts
Sources: At Market Issuance Sales Agreement (Geron Corp), At the Market Issuance Sales Agreement (Synta Pharmaceuticals Corp), At the Market Issuance Sales Agreement (Synta Pharmaceuticals Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Placement Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 7 contracts
Sources: Sales Agreement (Akebia Therapeutics, Inc.), Sales Agreement (Array Biopharma Inc), Sales Agreement (Verastem, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 7 contracts
Sources: Equity Distribution Agreement (Vizsla Silver Corp.), Equity Distribution Agreement (Vizsla Silver Corp.), Equity Distribution Agreement (HIVE Digital Technologies Ltd.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company under applicable laws and regulations to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentStock.
Appears in 7 contracts
Sources: Standby Equity Distribution Agreement (Omagine, Inc.), Standby Equity Distribution Agreement (Supertel Hospitality Inc), Standby Equity Distribution Agreement (Jag Media Holdings Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentCF&Co.
Appears in 6 contracts
Sources: Equity Distribution Agreement (Oncolytics Biotech Inc), Sales Agreement (Paragon Shipping Inc.), Sales Agreement (Oceanfreight Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Ordinary Shares or (ii) sell, bid for, or purchase Common Stock Ordinary Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 6 contracts
Sources: Sales Agreement (Nyxoah SA), Sales Agreement (Osmotica Pharmaceuticals PLC), Sales Agreement (Gamida Cell Ltd.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Preferred Stock or (ii) sell, bid for, or purchase Common Preferred Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 6 contracts
Sources: At Market Issuance Sales Agreement (Ontrak, Inc.), At Market Issuance Sales Agreement (Ontrak, Inc.), At the Market Issuance Sales Agreement (Spark Energy, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock the Placement Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 6 contracts
Sources: Sales Agreement (NightHawk Biosciences, Inc.), Common Stock Sales Agreement (Heat Biologics, Inc.), At Market Issuance Sales Agreement (Heat Biologics, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentDistribution Agents.
Appears in 6 contracts
Sources: At the Market Issuance Sales Agreement (LIGHTBRIDGE Corp), At Market Issuance Agreement (HomeStreet, Inc.), At Market Issuance Sales Agreement (Customers Bancorp, Inc.)
Market Activities. The Company will not, directly or indirectly, : (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Stock; or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAscendiant.
Appears in 6 contracts
Sources: At the Market Issuance Sales Agreement (Ault Alliance, Inc.), At the Market Issuance Sales Agreement (Ault Global Holdings, Inc.), At the Market Issuance Sales Agreement (IMAC Holdings, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock Shares or (ii) sell, bid for, or purchase Common Stock Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales Agent.
Appears in 6 contracts
Sources: Sales Agreement (Flora Growth Corp.), Sales Agreement (Aptose Biosciences Inc.), Sales Agreement (Power REIT)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentFBR.
Appears in 6 contracts
Sources: At Market Issuance Sales Agreement (Galectin Therapeutics Inc), At Market Issuance Sales Agreement (pSivida Corp.), At Market Issuance Sales Agreement (American Superconductor Corp /De/)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentBRFBR.
Appears in 5 contracts
Sources: At Market Issuance Sales Agreement (Novavax Inc), At Market Issuance Sales Agreement (Novavax Inc), At Market Issuance Sales Agreement (Novavax Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 5 contracts
Sources: At Market Issuance Sales Agreement (Centrus Energy Corp), At Market Issuance Sales Agreement (Sonim Technologies Inc), At Market Issuance Sales Agreement (Centrus Energy Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock Shares or (ii) during the Stand Off Period, sell, bid for, for or purchase the Common Stock in violation of Regulation MShares, or pay anyone any compensation for soliciting purchases of the Placement Common Shares other than the AgentBNYMCM.
Appears in 5 contracts
Sources: Sales Agency Financing Agreement (Washington Real Estate Investment Trust), Sales Agency Financing Agreement (Washington Real Estate Investment Trust), Sales Agency Financing Agreement (Washington Real Estate Investment Trust)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common shares of Preferred Stock or (ii) sell, bid for, or purchase Common shares of Preferred Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares Securities other than the AgentMLV.
Appears in 5 contracts
Sources: At the Market Issuance Sales Agreement (Resource Capital Corp.), At the Market Issuance Sales Agreement (Resource Capital Corp.), At the Market Issuance Sales Agreement (Resource Capital Corp.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentBP.
Appears in 5 contracts
Sources: At the Market Issuance Sales Agreement (Vical Inc), At the Market Issuance Sales Agreement (Microvision Inc), At the Market Issuance Sales Agreement (Microvision Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Ordinary Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation MOrdinary Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 5 contracts
Sources: Sales Agreement (TOYO Co., LTD), Sales Agreement (Inspira Technologies OXY B.H.N. LTD), Sales Agreement (Jiayin Group Inc.)
Market Activities. The Company has not and will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Placement Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 5 contracts
Sources: Sales Agreement (Transenterix Inc.), Sales Agreement (Durect Corp), Sales Agreement (Transenterix Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Placement Shares or (ii) sell, bid for, or purchase Common Stock Placement Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 5 contracts
Sources: Sales Agreement (HTG Molecular Diagnostics, Inc), Sales Agreement (Sophiris Bio Inc.), At Market Issuance Sales Agreement (Plug Power Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock Shares or (ii) sell, bid for, for or purchase the Common Stock in violation of Regulation MShares, or pay anyone any compensation for soliciting purchases of the Placement Common Shares other than the AgentBNYCMI.
Appears in 5 contracts
Sources: Sales Agency Financing Agreement (Southwest Gas Corp), Standby Equity Distribution Agreement (New Plan Excel Realty Trust Inc), Sales Agency Financing Agreement (Westar Energy Inc /Ks)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Placement Shares or (ii) sell, bid for, or purchase Common Stock Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentMLV.
Appears in 4 contracts
Sources: At Market Issuance Sales Agreement (Aeterna Zentaris Inc.), At Market Issuance Sales Agreement (Aeterna Zentaris Inc.), At Market Issuance Sales Agreement (Aeterna Zentaris Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to or that would constitute or that would reasonably be expected to cause or result in, under Securities Laws or that constitutes or would reasonably be expected to constituteotherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Offered Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Offered Shares, or pay anyone any compensation for soliciting purchases of the Placement Offered Shares other than the AgentAgents.
Appears in 4 contracts
Sources: Equity Distribution Agreement (POWERBANK Corp), Equity Distribution Agreement (SolarBank Corp), Equity Distribution Agreement (SolarBank Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to or that would constitute or that would reasonably be expected to cause or result in, under Applicable Securities Laws or that constitutes or would reasonably be expected to constituteotherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.Agents. The Company will, and shall cause each of its affiliates to, comply with all applicable provisions of Regulation M.
Appears in 4 contracts
Sources: Equity Distribution Agreement (Trilogy Metals Inc.), Equity Distribution Agreement (Platinum Group Metals LTD), Equity Distribution Agreement (Trilogy Metals Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Class A Ordinary Shares or (ii) sell, bid for, or purchase Common Stock Class A Ordinary Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales Agent.
Appears in 4 contracts
Sources: Sales Agreement (China SXT Pharmaceuticals, Inc.), Sales Agreement (SKK Holdings LTD), Sales Agreement (Chanson International Holding)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentFBR.
Appears in 4 contracts
Sources: At Market Issuance Sales Agreement (ITUS Corp), At Market Issuance Sales Agreement (Parkervision Inc), At Market Issuance Sales Agreement (Soligenix, Inc.)
Market Activities. The Company will not, directly or indirectly, without giving effect to activities by the Agent (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock in violation of Regulation M under the Exchange Act or (ii) sell, bid for, or purchase Common Stock in violation of Regulation MStock, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 4 contracts
Sources: Sales Agreement (Ardelyx, Inc.), Sales Agreement (Ardelyx, Inc.), Sales Agreement (Signal Genetics, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 4 contracts
Sources: Sales Agreement (BioCardia, Inc.), Sales Agreement (EyePoint Pharmaceuticals, Inc.), Sales Agreement (vTv Therapeutics Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of shares of Common Stock or (ii) sell, bid for, or purchase shares of Common Stock in violation of Regulation MStock, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentManagers.
Appears in 4 contracts
Sources: At the Market Offering Agreement, At the Market Offering Agreement (India Globalization Capital, Inc.), At the Market Offering Agreement (India Globalization Capital, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Preferred Stock or (ii) sell, bid for, or purchase Common Preferred Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentMLV.
Appears in 4 contracts
Sources: At Market Issuance Sales Agreement (Miller Energy Resources, Inc.), At Market Issuance Sales Agreement (Adcare Health Systems Inc), At the Market Issuance Sales Agreement (Evolution Petroleum Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Placement Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 4 contracts
Sources: At Market Issuance Sales Agreement (Horizon Technology Finance Corp), At Market Issuance Sales Agreement (Horizon Technology Finance Corp), At Market Issuance Sales Agreement (Horizon Technology Finance Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation MM under the Exchange Act, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 4 contracts
Sources: Sales Agreement (Solana Co), Sales Agreement (Helius Medical Technologies, Inc.), Sales Agreement (RAPT Therapeutics, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent▇▇▇▇▇.
Appears in 4 contracts
Sources: Sales Agreement (Dynavax Technologies Corp), Sales Agreement (Dynavax Technologies Corp), Sales Agreement (Dynavax Technologies Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) during the Stand Off Period, sell, bid for, for or purchase Common Stock in violation of Regulation Mthe Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentBNYMCM.
Appears in 4 contracts
Sources: Sales Agency Financing Agreement (DDR Corp), Sales Agency Financing Agreement (Developers Diversified Realty Corp), Sales Agency Financing Agreement (Developers Diversified Realty Corp)
Market Activities. The Company will not, directly or indirectly, : (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Stock; or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 4 contracts
Sources: At the Market Issuance Sales Agreement (ENDRA Life Sciences Inc.), At the Market Issuance Sales Agreement (ENDRA Life Sciences Inc.), At the Market Issuance Sales Agreement (ENDRA Life Sciences Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Shares to be issued and sold pursuant to this Agreement, or pay anyone any compensation for soliciting purchases of the Placement Shares to be issued and sold pursuant to this Agreement other than the AgentUnderwriters.
Appears in 4 contracts
Sources: Underwriting Agreement (Summit Hotel Properties, Inc.), Underwriting Agreement (Summit Hotel Properties, Inc.), Underwriting Agreement (Summit Hotel Properties, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Placement Shares to be issued and sold pursuant to this Agreement, or pay anyone any compensation for soliciting purchases of the Placement Shares to be issued and sold pursuant to this Agreement other than the Agent.
Appears in 4 contracts
Sources: At Market Issuance Sales Agreement (Armour Residential REIT, Inc.), Equity Distribution Agreement (Armour Residential REIT, Inc.), At Market Issuance Sales Agreement (Armour Residential REIT, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Shares or (ii) sell, bid for, or purchase Common Stock Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 4 contracts
Sources: Sales Agreement (Evogene Ltd.), Sales Agreement (Evogene Ltd.), Sales Agreement (Evogene Ltd.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, or purchase the Common Stock in violation of Regulation Mto be issued and sold pursuant to this Agreement, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent▇▇▇▇▇.
Appears in 3 contracts
Sources: Sales Agreement (Trevena Inc), Sales Agreement (Trevena Inc), Sales Agreement (Trevena Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Ordinary Shares or (ii) sell, bid for, or purchase Common Stock Ordinary Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 3 contracts
Sources: At Market Issuance Sales Agreement (Bitfufu Inc.), At Market Issuance Sales Agreement (Sono Group N.V.), At Market Issuance Sales Agreement (Fusion Fuel Green PLC)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Class A Ordinary Shares underlying the Class A Ordinary Shares or (ii) sell, bid for, or purchase Common Stock Class A Ordinary Shares underlying the Class A Ordinary Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales Agent.
Appears in 3 contracts
Sources: Sales Agreement (Paranovus Entertainment Technology Ltd.), Sales Agreement (Mingteng International Corp Inc.), Sales Agreement (HiTek Global Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Ordinary Shares or (ii) sell, bid for, or purchase Common Stock Ordinary Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 3 contracts
Sources: At Market Issuance Sales Agreement (Bitdeer Technologies Group), At Market Issuance Sales Agreement (Bitdeer Technologies Group), At Market Issuance Sales Agreement (Bitdeer Technologies Group)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 3 contracts
Sources: Sales Agreement (Ampio Pharmaceuticals, Inc.), Sales Agreement (Karyopharm Therapeutics Inc.), Sales Agreement (Pdi Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Ordinary Shares or (ii) sell, bid for, or purchase Common Stock Ordinary Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 3 contracts
Sources: At Market Issuance Sales Agreement (OKYO Pharma LTD), At Market Issuance Sales Agreement (Entera Bio Ltd.), At Market Issuance Sales Agreement (Entera Bio Ltd.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 3 contracts
Sources: Sales Agreement (fuboTV Inc. /FL), Sales Agreement (fuboTV Inc. /FL), Sales Agreement (Savara Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentWestpark.
Appears in 3 contracts
Sources: At the Market Issuance Sales Agreement (Houston American Energy Corp), At the Market Issuance Sales Agreement (Houston American Energy Corp), At the Market Issuance Sales Agreement (Houston American Energy Corp)
Market Activities. The Company will not, directly or indirectly, : (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares; or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents.
Appears in 3 contracts
Sources: Equity Distribution Agreement (HIVE Digital Technologies Ltd.), Equity Distribution Agreement (HIVE Digital Technologies Ltd.), Equity Distribution Agreement (HIVE Digital Technologies Ltd.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Class A Ordinary Shares or (ii) sell, bid for, or purchase Common Stock the Class A Ordinary Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales Agent.
Appears in 3 contracts
Sources: Sales Agreement (INLIF LTD), Sales Agreement (WORK Medical Technology Group LTD), Sales Agreement (Li Bang International Corp Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock ADSs or (ii) sell, bid for, or purchase Common Stock Ordinary Shares or ADSs in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 3 contracts
Sources: Sales Agreement (Chemomab Therapeutics Ltd.), Sales Agreement (Chemomab Therapeutics Ltd.), Sales Agreement (Chemomab Therapeutics Ltd.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock Shares or (ii) during any Stand Off Period sell, bid for, for or purchase the Common Stock in violation of Regulation MShares, or pay anyone any compensation for soliciting purchases of the Placement Common Shares other than the Agent.;
Appears in 3 contracts
Sources: Sales Agency Financing Agreement (Boston Properties Inc), Sales Agency Financing Agreement (Boston Properties Inc), Sales Agency Financing Agreement (Boston Properties Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 3 contracts
Sources: At Market Issuance Sales Agreement (Novavax Inc), At Market Issuance Sales Agreement (Novavax Inc), At Market Issuance Sales Agreement (Novavax Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares Notes other than the AgentBRFBR.
Appears in 3 contracts
Sources: At Market Issuance Sales Agreement (B. Riley Financial, Inc.), At Market Issuance Sales Agreement (B. Riley Financial, Inc.), At Market Issuance Sales Agreement (B. Riley Financial, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock Shares or (ii) sell, bid for, for or purchase the Common Stock in violation of Regulation MShares, or pay anyone any compensation for soliciting purchases of the Placement Common Shares other than the AgentBNYMCM.
Appears in 3 contracts
Sources: Sales Agency Agreement (Idaho Power Co), Sales Agency Agreement (Idacorp Inc), Sales Agency Agreement (Idacorp Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation MShares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 3 contracts
Sources: Sales Agreement (Epsilon Energy Ltd.), Sales Agreement (GREENPOWER MOTOR Co INC.), Sales Agreement (GREENPOWER MOTOR Co INC.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Placement Shares or (ii) sell, bid for, or purchase Common Stock Placement Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 3 contracts
Sources: Equity Distribution Agreement (Orchids Paper Products CO /DE), Sales Agreement (Orexigen Therapeutics, Inc.), Sales Agreement (Eiger BioPharmaceuticals, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of shares of Common Stock or (ii) sell, bid for, or purchase shares of Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent.
Appears in 3 contracts
Sources: Sales Agreement (Cumberland Pharmaceuticals Inc), At Market Issuance Sales Agreement (Gse Systems Inc), At Market Issuance Sales Agreement (ViewRay, Inc.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the ADSs or (ii) sell, bid for, or purchase Common Stock shares of Ordinary Shares or ADSs in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales Agent.
Appears in 3 contracts
Sources: Sales Agreement (Foresight Autonomous Holdings Ltd.), Sales Agreement (Foresight Autonomous Holdings Ltd.), Sales Agreement (Foresight Autonomous Holdings Ltd.)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Shares or (ii) sell, bid for, for or purchase Common Stock in violation of Regulation Mthe Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Sales Agent and the Alternative Sales Agent.
Appears in 3 contracts
Sources: Sales Agency Agreement, Sales Agency Agreement (Avista Corp), Sales Agency Agreement (Avista Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock Shares or (ii) during the Stand-Off Period, sell, bid for, for or purchase the Common Stock in violation of Regulation MShares, or pay anyone any compensation for soliciting purchases of the Placement Common Shares other than the AgentBNYMCM.
Appears in 3 contracts
Sources: Sales Agency Agreement (Southwest Gas Holdings, Inc.), Sales Agency Agreement (Southwest Gas Holdings, Inc.), Sales Agency Agreement (Southwest Gas Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock the Placement Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation Mthe Placement Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentMLV.
Appears in 3 contracts
Sources: At Market Issuance Sales Agreement (Peregrine Pharmaceuticals Inc), At Market Issuance Sales Agreement (Peregrine Pharmaceuticals Inc), At Market Issuance Sales Agreement (Peregrine Pharmaceuticals Inc)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock or (ii) sell, bid for, or purchase shares of Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentUnivest.
Appears in 3 contracts
Sources: At the Market Issuance Sales Agreement (Houston American Energy Corp), At the Market Issuance Sales Agreement (Houston American Energy Corp), At the Market Issuance Sales Agreement (Houston American Energy Corp)
Market Activities. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock Class A Shares or (ii) sell, bid for, or purchase Common Stock Class A Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the AgentAgents, the Forward Purchasers or the Forward Sellers.
Appears in 3 contracts
Sources: At the Market Issuance Sales Agreement (American Homes 4 Rent), At the Market Issuance Sales Agreement (American Homes 4 Rent), At the Market Issuance Sales Agreement (American Homes 4 Rent)